Subcellular localization of OsKO1 and OsKO2, and expression analyses on their encoding genes. by Hui Zhang (7197)

Image1.JPEG by Swetlana Gautam (5069798)

“…<p>The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. …”

Image4.JPEG by Swetlana Gautam (5069798)

“…<p>The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. …”

Image2.JPEG by Swetlana Gautam (5069798)

“…<p>The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. …”

Image3.JPEG by Swetlana Gautam (5069798)

“…<p>The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. …”

Image6.JPEG by Swetlana Gautam (5069798)

“…<p>The present study is a pursuit to define implications of dual cyclooxygenase-2 (COX-2) and 5-lipoxygenase (5-LOX) (DuCLOX-2/5) inhibition on various aspects of cancer augmentation and chemoprevention. …”

Main karyotypic groups/types distinguished among <i>T</i>. <i>dicoccon</i> accessions on the basis of visual analysis of C-banding patterns. by Ekaterina D. Badaeva (746941)

“…Large black arrows show the breakpoint position in region-specific translocation variants: T7AS.7AL-5BS and T5BL.5BS-7AL—rearranged chromosomes formed as a result of the T7A:5B translocation; T4AS:1BL and T1BS:4AL—rearranged chromosomes formed as a result of the T4A:1B translocation; T1AS.1AL-6AS and T6AL.6AS-1AL—rearranged chromosomes formed as a result of the T1A:6A translocation; T4BS:6BL and T6BS:4BL—rearranged chromosomes formed as a result of the T4B:6B-1 translocation (see <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0128556#pone.0128556.s016" target="_blank">S3</a> and <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0128556#pone.0128556.s017" target="_blank">S4</a> Tables).…”

Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis <i>in vitro</i> and <i>in vivo</i> by Hongrui Cui (12001906)

“…<p>Acute kidney injury (AKI) is a common complication of sepsis and increase morbidity and mortality. …”

Characteristics at enrolment, Nairobi. by Faith Magut (15447266)

“…We found evidence of an increase in HIV status knowledge(10.0% [95%CI:4.5,15.2]), social support(27.2% [95%CI:19.2,35.5]) and a decrease in condomless sex(-9.1% [95%CI:-13.6,-4.1]), and the proportion with ≥2 lifetime partners(-7.6% [95%CI:-12.4,-2.2]) for the complete package. …”

Layering of DREAMS interventions in Kenya. by Faith Magut (15447266)

“…We found evidence of an increase in HIV status knowledge(10.0% [95%CI:4.5,15.2]), social support(27.2% [95%CI:19.2,35.5]) and a decrease in condomless sex(-9.1% [95%CI:-13.6,-4.1]), and the proportion with ≥2 lifetime partners(-7.6% [95%CI:-12.4,-2.2]) for the complete package. …”

Social support, 2019 – Sensitivity analyses. by Faith Magut (15447266)

“…We found evidence of an increase in HIV status knowledge(10.0% [95%CI:4.5,15.2]), social support(27.2% [95%CI:19.2,35.5]) and a decrease in condomless sex(-9.1% [95%CI:-13.6,-4.1]), and the proportion with ≥2 lifetime partners(-7.6% [95%CI:-12.4,-2.2]) for the complete package. …”

Characteristics at enrolment, Gem. by Faith Magut (15447266)

“…We found evidence of an increase in HIV status knowledge(10.0% [95%CI:4.5,15.2]), social support(27.2% [95%CI:19.2,35.5]) and a decrease in condomless sex(-9.1% [95%CI:-13.6,-4.1]), and the proportion with ≥2 lifetime partners(-7.6% [95%CI:-12.4,-2.2]) for the complete package. …”

Supplementary Material for: Novel Cranial Imaging Findings and a Splice-Site Variant in a Patient with Tyrosinemia Type III, and a Summary of Published Cases by Kahraman A.B. (11900960)

Development of Potent and Selective Monoacylglycerol Lipase Inhibitors. SARs, Structural Analysis, and Biological Characterization by Stefania Butini (1714288)

“…The most promising compounds ((±)-<b>5c</b>, (±)-<b>5d</b>, and (±)-<b>5v</b>) were used for <i>in vivo</i> studies in mice, showing a decrease in MAGL activity and increased 2-arachidonoyl-<i>sn</i>-glycerol levels in forebrain tissue. …”

<i>ASA1</i> acts downstream of ERF1. by Jie-Li Mao (844282)

PP2B dephosphorylates pS295 <i>in vitro</i>. by Takahiko Chimura (729098)

Real-time NO release profiles of the HPMC/GSNO formulations. by Maria Adriana Skeff (670466)

Quantification of immunohistochemical staining of oral myofibroblasts using an anti-Ki67 antibody. by Maria Adriana Skeff (670466)

Study design scheme. by Leonardo Suveges Moreira Chaves (5554235)

ERF1 directly binds to <i>ASA1</i> promoter region <i>in vitro</i> and <i>in vivo</i>. by Jie-Li Mao (844282)